We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Oncolytics Biotech® Announces 2011 Year End Results

News   Apr 02, 2012

 
Oncolytics Biotech® Announces 2011 Year End Results
 
 
Advertisement
 

RELATED ARTICLES

Cells Inside Cells: The Bacteria That Live in Cancer Cells

News

Cancer cells are comfy havens for bacteria. That conclusion arises from a rigorous study of over 1,000 tumor samples of different human cancers, which found bacteria living inside the cells of all the cancer types – from brain to bone to breast cancer – and even identified unique populations of bacteria residing in each type of cancer.

READ MORE

FDA Grants Fast Track Designation to Onvansertib for Second-line Treatment of KRAS-mutated Colorectal Cancer

News

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

READ MORE

Blocking Tumor Signaling To Suppress the Spread of Melanoma

News

A team of researchers has suppressed the spread of melanoma to the lungs in a mouse model using an inhibitor of an enzyme called p38α kinase.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE